0000-0002-3485-8369 Employment
-
IISER - Bhopal Assistant Professor2024 - Present
-
The Wistar Institute Post Doctoral Fellow2019 - 2024
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- Siglecs in immunotherapy: current clinical landscape and prospects Save
- Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Save
- Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Save
- Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. Save
- Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers. Save
- A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. Save
- In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme. Save
- Loss of TIPE3 reduced the proliferation, survival and migration of lung cancer cells through inactivation of Akt/mTOR, NF-κB, and STAT-3 signaling cascades. Save
- Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases. Save
- Xanthohumol from Hop: Hope for cancer prevention and treatment. Save